The efficacy and safety of lecanemab 10mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials
General Info
Coverage type
Global
Time period covered
January, 2016 - December, 2023
Data type
Scientific literature
Citation
Journal
Neurol Sci
Pages
3583-3597
Publication year
2024
Suggested citation
Abdelazim K, Allam AA, Afifi B, Abdulazeem H, Elbehiry AI. The efficacy and safety of lecanemab 10mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. Neurol Sci. 2024; 45(8): 3583-3597.